In Vivo SPECT and Real-Time Gamma Camera Imaging of Biodistribution and Pharmacokinetics of siRNA Delivery Using an Optimized Radiolabeling and Purification Procedure

被引:81
作者
Merkel, Olivia M. [1 ]
Librizzi, Damiano [2 ]
Pfestroff, Andreas [2 ]
Schurrat, Tino [2 ]
Behe, Martin [2 ,3 ]
Kissel, Thomas [1 ]
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
[2] Univ Hosp Giessen & Marburg GmbH, Dept Nucl Med, D-35043 Marburg, Germany
[3] Univ Freiburg, Dept Nucl Med, D-79106 Freiburg, Germany
关键词
INTRAVENOUS-INJECTION; MOLECULAR-WEIGHT; PLASMID DNA; POLYETHYLENIMINE; RNA; COMPLEXES; INHIBITION; POLYPLEXES; PEGYLATION; SYSTEM;
D O I
10.1021/bc800408g
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Single photon emission computed tomography (SPECT) imaging provides a three-dimensional method for exactly locating gamma emitters in a noninvasive procedure under in vivo conditions. For characterization of siRNA delivery systems, molecular imaging techniques are extremely helpful to follow biodistribution under in experimental animal studies. Quantification of biodistribution of siRNA and nonviral delivery systems using this technique requires efficient methods to stably label siRNA with a gamma emitter (e.g., In-111 or Tc-99m) and to purify labeled material from excesses of radiolabel or linkers. In the following study, we have optimized labeling and purification of siRNA, which was then applied as free siRNA or after complexation with polyethylenimine (PEI) 25 kDa for in vivo real-time gamma camera and SPECT imaging. Quantification of scintillation counts in regions of interest (ROIs) was compared to conventional scintillation counting of dissected organs, and the data acquired by imaging was shown to corroborate that of scintillation counting. This optimization and proof of principle study demonstrates that biodistribution and pharmacokinetics of siRNA and the corresponding polyplexes can be determined using SPECT, leading to comparable results as conventional methodology.
引用
收藏
页码:174 / 182
页数:9
相关论文
共 34 条
[1]  
Barendswaard EC, 1998, INT J ONCOL, V12, P45
[2]   Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles [J].
Bartlett, Derek W. ;
Davis, Mark E. .
BIOTECHNOLOGY AND BIOENGINEERING, 2008, 99 (04) :975-985
[3]   Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging [J].
Bartlett, Derek W. ;
Su, Helen ;
Hildebrandt, Isabel J. ;
Weber, Wolfgang A. ;
Davis, Mark E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (39) :15549-15554
[4]  
BEHIKE MA, 2006, MOL THER, V13, P644
[5]   Biodistribution of phosphodiester and phosphorothioate siRNA [J].
Braasch, DA ;
Paroo, Z ;
Constantinescu, A ;
Ren, G ;
Öz, OK ;
Mason, RP ;
Corey, DR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) :1139-1143
[6]   RNAi therapeutics: a potential new class of pharmaceutical drugs [J].
Bumcrot, David ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
Sah, Dinah W. Y. .
NATURE CHEMICAL BIOLOGY, 2006, 2 (12) :711-719
[7]   Side-effects of a systemic injection of linear polyethylenimine-DNA complexes [J].
Chollet, P ;
Favrot, MC ;
Hurbin, A ;
Coll, JL .
JOURNAL OF GENE MEDICINE, 2002, 4 (01) :84-91
[8]  
Clarke K, 2000, CANCER RES, V60, P4804
[9]   siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma [J].
de Martimprey, Henri ;
Bertrand, Jean-Remi ;
Fusco, Alfredo ;
Santoro, Massimo ;
Couvreur, Patrick ;
Vauthier, Christine ;
Malvy, Claude .
NUCLEIC ACIDS RESEARCH, 2008, 36 (01)
[10]   Scintigraphic imaging of HSVtk gene therapy [J].
de Vries, EFJ ;
Buursma, AR ;
Hospers, GAP ;
Mulder, NH ;
Vaalburg, W .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (16) :1435-1450